Has Abdel Kader Tal, MD received payments from drug or device companies?

Yes. Drug and device makers reported $3,155 in general payments to Abdel Kader Tal, MD across 58 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Abdel Kader Tal, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Abdel Kader Tal, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Abdel Kader Tal, MD

MOHS-Micrographic Surgery · Perrysburg, OHNPI 1972708105

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 58 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 20.8% — the pattern of someone who eats at a lot of different presentations.

$3,155in general payments, 2019–2025

Across 58 payments — averaging $54.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$657
Novartis$411
Janssen Scientific Affairs, LLC$321
Pfizer$282
Galderma Laboratories, L.p.$259
E.r. Squibb & Sons, L.L.C.$228
plus $998 from 11 others

What the payments were for

Food & beverage$3,155100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	15	$657
Novartis	7	$411
Janssen Scientific Affairs, LLC	3	$321
Pfizer	3	$282
Galderma Laboratories, L.p.	5	$259
E.r. Squibb & Sons, L.L.C.	4	$228
LEO Pharma Inc.	2	$153
Dermavant Sciences, Inc.	2	$150
Johnson & Johnson	4	$138
Boehringer Ingelheim	1	$125
Lilly USA, LLC	3	$115
Sanofi	1	$95
Regeneron Healthcare Solutions, Inc.	1	$77
Sun Pharmaceutical Industries Inc.	3	$51
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	1	$45
UCB, Inc.	2	$33
Almirall LLC	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

COSENTYX$374
Tremfya$321
Sotyktu$126
Skyrizi$126
Rinvoq$125
SPEVIGO$125
CIBINQO$124
VTAMA$124
NEMLUVIO$121
UBRELVY$108

How this compares

$3,155 in reported general payments places this provider in the 75th percentile of 35 mohs-micrographic surgery providers in Ohio.

See all mohs-micrographic surgery providers in Ohio →

Medicare billing

Part B allowed, 2024

$451,996

Medicare patients

517

Services billed

2,877

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Fluorouracil	72	$6,082
Clobetasol Propionate	74	$2,741
Doxycycline Monohydrate	160	$2,155
Fluocinonide	50	$1,769
Metronidazole	19	$1,021
Imiquimod	33	$939
Triamcinolone Acetonide	54	$610
Mometasone Furoate	21	$338
Ketoconazole	28	$313
Doxycycline Hyclate	16	$205
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim	29	$137
Cephalexin	29	$128
Hydrocortisone	29	$102
Minoxidil	13	$65
Prednisone	13	$58

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in Perrysburg

Jorge Garcia ZuazagaConcord Township$149K
Morgan HottWarren$16K
Jennifer PopovskyMedina$15K
Justin WoodhouseMayfield Heights$7K
Mihir ShahWestlake$5K
Allison MoosallyFairlawn$5K
Kathleen NemerAthens$3K
Patrick KillianWestlake$3K
Alison DurhamCanton$3K
Larisa RavitskiyNew Albany$3K

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →